Key facts
- Riverain Technologies’s last known valuation is $75.0M (Sep 2019).
- It has raised $23.3M across 1 recorded rounds; the latest was Early Stage VC ($8.3M) in Dec 2025.
- Notable investors include John Rompon, Mercom Capital Group, Ping An Voyager Partners.
- Riverain Technologies has filed 1 Form D with the SEC, most recently Jan 2026 ($8.3M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Riverain Technologies
Funding rounds
1 roundsAbout Riverain Technologies
Developer of an image enhancement software designed to aid the clinician in the early detection of lung diseases. The company's software facilitates decision-making, using thoracic imaging for the detection of lung diseases and other clinical conditions, as well as provides a vessel-suppressed CT series that removes the challenging vascular structure, enabling radiologists to get the most out of chest X-ray imaging, to complete more reads faster, and save time and money.
- Sector
- Healthcare
- HQ
- Miamisburg, OH, United States
- Founded
- 2004
- Employees
- 50
- Website
- riveraintech.com/
- Ownership
- Privately Held (backing)
Riverain Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Riverain Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Riverain Technologies in its N-PORT filings yet. We sweep new filings monthly.